1. Cannon CP, Braunwald E, McCabe CH, et al. The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. J Interv Cardiol. 1995; 8(2):117–135.10.1111/j.1540-8183.1995.tb00526.x
2. Bahit MC, Cannon CP, Antman EM, et al. Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. Am Heart J. 2003; 145: 109–117.10.1067/mhj.2003.43
3. Hartzler GO, Rutherford BD, Mc Conahy DR, et all. : Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983, 106: 965-97310.1016/0002-8703(83)90639-7
5. Stone GW. Stenting and IIb/IIIa receptor blockade in acute myocardial infarction: an introduction to the CADILLAC trial. J Invas Cardiol 1998;10(suppl B):36B-47B
6. Mehran R, Pocock S, Nikolsky E, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-levelpooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trials. J Am Coll CardiolIntv 2011; 4:654–64.10.1016/j.jcin.2011.02.011
7. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The ACCESS study. J Am Coll Cardiol 1997; 29:1269–1275.10.1016/S0735-1097(97)00064-8
9. Mamas MA, Ratib K, Routledge H, et al. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention. Are the results of randomized trials achievable in clinical practice? JACC Cardiovasc Interv. 2013;6(7):698-70610.1016/j.jcin.2013.03.011
10. Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv.2008;1(2):202-20910.1016/j.jcin.2007.12.006
11. Hamon M, Pristipino C, Di Mario C, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the EAPCI and Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology. EuroIntervention. 2013; 8(11):1242-1251.10.4244/EIJV8I11A192
12. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHAguideline for the management of ST-elevation myocardial infarction: report of the American College оf Cardiology-Foundation/AmericanHeart Association Task Force on Practice Guidelines. J Am CollCardiol 2013;61:e78–140
13. Bernat I, Horak D, Stasek J, Mates M, et al. STEMI-RADIAL: a prospective randomized trial of radial vs. femoral access in patients with ST-segment elevation myocardial infarction. Paper presented at: Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium; October 26, 2012; Miami, FL.
14. Altman DG. Relation between several variables. In: Altman DG, ed. Practical statistics for medical research. London: Chapman and Hall; 1991. p. 325-61.
17. Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol2010; 55:2187–95.10.1016/j.jacc.2010.01.03920466199
18. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitionsfor cardiovascular clinical trials: a consensus report from the BleedingAcademic Research Consortium. Circulation 2011;123:2736–4710.1161/CIRCULATIONAHA.110.009449
19. Moher D, Dulberg S C, Wells G. Statistical Power, Sample Size, and Their Reporting in Randomized Controlled Trials. JAMA. 1994;272:122-12410.1001/jama.1994.03520020048013
21. Hetherington S L et al. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart 2009 95: 1612-161810.1136/hrt.2009.170233
22. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, et al. Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. J Am Coll Cardiol 2012; 60:2481–9.10.1016/j.jacc.2012.06.017
23. Jolly SS, Yusuf S, Cairns J, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377(9775):1409-142010.1016/S0140-6736(11)60404-2
24. Jolly SS, Amlani S, Hamon M, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157:132–14010.1016/j.ahj.2008.08.02319081409
25. Rao SV, Ou FS, Wang TY, et al. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. J Am Coll Cardiol Intv 2008; 1:379–386.10.1016/j.jcin.2008.05.00719463333
26. Mamas MA, Ratib K, Routledge H, et al. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart. 2012;98(4):303-31110.1136/heartjnl-2011-30055822147900